Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
Dec 01, 2008 07:01 PM
- FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
Nov 20, 2008 09:03 AM
- Vanda Pharmaceuticals Reports Third Quarter 2008 Results
Oct 30, 2008 07:01 AM
- Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
Sep 25, 2008 09:41 AM
- Vanda Pharmaceuticals Provides Update on Iloperidone
Sep 11, 2008 09:12 AM
- Vanda Pharmaceuticals Reports Second Quarter 2008 Results
Aug 05, 2008 06:30 AM
- BeaconEquity.com Issues Technical Trade Alerts on Market Movers: ZONS, SSCC, VNDA, DSTI, XOMA, GNVC
Aug 01, 2008 09:57 AM
- Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
Jul 31, 2008 01:47 PM
- Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
Jul 28, 2008 06:30 AM
- Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Jun 26, 2008 06:30 AM
- Form 4 Vanda Pharmaceuticals For: Nov 07 Filed by: TANG CAPITAL PARTNERS LP (10K)
Nov 12, 2008 10:01 PM
- Form 4 Vanda Pharmaceuticals For: Sep 15 Filed by: TANG CAPITAL PARTNERS LP (10K)
Nov 12, 2008 09:57 PM
- Form 3 Vanda Pharmaceuticals For: Sep 25 Filed by: TANG CAPITAL PARTNERS LP (10K)
Nov 12, 2008 09:56 PM
- Form 4 Vanda Pharmaceuticals For: Sep 23 Filed by: TANG CAPITAL PARTNERS LP (10K)
Sep 25, 2008 07:04 PM
- Form 4 Vanda Pharmaceuticals For: Sep 22 Filed by: TANG CAPITAL PARTNERS LP (10K)
Sep 24, 2008 10:25 PM
- Form 4 Vanda Pharmaceuticals For: Sep 19 Filed by: TANG CAPITAL PARTNERS LP (10K)
Sep 23, 2008 08:56 PM
- Form 3 TANG KEVIN C For: Sep 09 (10K)
Sep 19, 2008 09:16 PM
- Form 4 Vanda Pharmaceuticals For: Aug 20 Filed by: Polymeropoulos Mihael Hristos (10K)
Aug 22, 2008 10:25 AM
- Form 4 Vanda Pharmaceuticals For: Aug 11 Filed by: Polymeropoulos Mihael Hristos (10K)
Aug 12, 2008 10:08 AM
- Form 4 Vanda Pharmaceuticals For: Aug 07 Filed by: Polymeropoulos Mihael Hristos (10K)
Aug 11, 2008 02:24 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
VNDA
|
Compare to S&P
|
| YTD |
-90.55 %
|
-84.52 %
|
| 4 Weeks |
-20.73 %
|
-14.32 %
|
| 12 Weeks |
-36.89 %
|
-12.52 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 19.61 %
|
|
EPS Growth in Last Year: 50.00 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
